High Intensity Drug Trafficking Areas; Petitions for Designation, 30862-30864 [E7-10640]
Download as PDF
<![CDATA[
30862
Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices
Family of one
Family of two
Family of three
Family of four
Family of five
Family of six
12,470
12,680
12,690
12,990
13,400
13,500
13,620
13,740
13,790
13,870
14,230
14,400
15,400
15,610
16,440
16,700
20,440
20,780
20,790
21,290
21,960
22,120
22,310
22,520
22,600
22,730
23,320
23,590
25,230
25,580
26,940
27,360
28,060
28,530
28,540
29,220
30,150
30,360
30,630
30,910
31,020
31,200
32,020
32,390
34,640
35,110
36,980
37,560
34,630
35,220
35,230
36,070
37,220
37,480
37,810
38,160
38,290
38,510
39,520
39,980
42,760
43,340
45,650
46,370
40,870
41,560
41,580
42,570
43,920
44,230
44,620
45,030
45,190
45,450
46,640
47,180
50,460
51,150
53,870
54,720
47,790
48,610
48,620
49,780
51,370
51,730
52,180
52,670
52,850
53,150
54,540
55,180
59,010
59,810
63,000
64,000
[FR Doc. E7–10662 Filed 6–1–07; 8:45 am]
EXECUTIVE OFFICE OF THE
PRESIDENT
BILLING CODE 4510–FT–P
Office of National Drug Control Policy
FEDERAL MINE SAFETY AND HEALTH
REVIEW COMMISSION
High Intensity Drug Trafficking Areas;
Petitions for Designation
Office of National Drug Control
Policy.
ACTION: Notice.
AGENCY:
Sunshine Act Meeting Notice;
Correction
May 23, 2007.
TIME AND DATE:
10 a.m., Thursday, May
31, 2007.
The Richard V. Backley Hearing
Room, 9th Floor, 601 New Jersey
Avenue, NW., Washington, DC.
PLACE:
STATUS:
Open.
The
Commission will consider and act upon
the following in open session: Jaxun v.
Asarco, LLC, Docket No. WEST 2006–
416–DM. (Issues include whether the
Administrative Law Judge erred in
requiring a miner pursuing a claim
under section 105(c)(3) of the Federal
Mine Safety and Health Act of 1977, 30
U.S.C. 815(c)(3), to obtain
representation or risk dismissal of his
claim.)
Any person attending this meeting
who requires special accessibility
features and/or auxiliary aids, such as
sign language interpreters, must inform
the Commission in advance of those
needs. Subjects to 29 CFR 2706.150(a)(3)
and 2706.160(d).
MATTERS TO BE CONSIDERED:
Jean
Ellen, (202) 434–9950/(202) 708–9300
for TDD Relay 1–800–877–8339 for toll
free.
rwilkins on PROD1PC63 with NOTICES
CONTACT PERSON FOR MORE INFO:
Jean H. Ellen,
Chief Docket Clerk.
[FR Doc. 07–2785 Filed 5–31–07; 11:28 am]
BILLING CODE 6735–01–M
VerDate Aug<31>2005
20:34 Jun 01, 2007
Jkt 211001
SUMMARY: Pursuant to the Office of
National Drug Control Policy
Reauthorization Act of 2006, Public Law
109–469, section 707(c), the Director,
National Drug Control Policy is
establishing regulations under which
interested coalitions of law enforcement
agencies from an area may petition for
designation as a high intensity drug
trafficking area.
DATES: Comments must be received by
ONDCP on or before August 3, 2007.
ADDRESSES: Written comments may be
submitted through electronic mail at
ondcp_hidta@ondcp.eop.gov, or via
facsimile at (202) 395–6721 to Executive
Office of the President, Office of
National Drug Control Policy, Office of
State, Local and Tribal Affairs,
Washington, DC 20503.
FOR FURTHER INFORMATION CONTACT: Mr.
Daniel Grayson, Policy Analyst, Office
of State, Local, and Tribal Affairs,
Executive Office of the President, Office
of National Drug Control Policy, 750
17th Street, NW., Washington, DC
20503; DGrayso@ondcp.eop.gov; (202)
395–4582 (This is not a toll-free
number).
SUPPLEMENTARY INFORMATION: The AntiDrug Abuse Act of 1988, the ONDCP
Reauthorization Act of 1998, and the
ONDCP Reauthorization Act of 2006
authorize the Director of the Office of
National Drug Control Policy (ONDCP)
to designate areas within the United
States that exhibit serious drug
trafficking problems and harmful impact
PO 00000
Frm 00120
Fmt 4703
Sfmt 4703
of other areas of the country as High
Intensity Drug Trafficking Areas
(HIDTA). The HIDTA Program provides
federal resources to those areas to help
eliminate or reduce drug trafficking and
its harmful consequences. Law
enforcement organizations within
HIDTAs assess drug trafficking
problems and design specific initiatives
to reduce of eliminate the production,
manufacture, transportation,
distribution, and use of illegal drugs and
money laundering.
When designating a new HIDTA or
adding counties to existing HIDTAs, the
Director of ONDCP consults with the
Attorney General, Secretary of
Homeland Security, Secretary of
Treasury, heads of national drug control
agencies, and the appropriate governors,
and considers the extent to which—
(1) The area is a significant center of
illegal drug production, manufacturing,
importation, or distribution;
(2) State, local, and tribal law
enforcement agencies have committed
resources to respond to the drug
trafficking problem in the area, thereby
indicating a determination to respond
aggressively to the problem;
(3) Drug-related activities in the area
are having a significant harmful impact
in the area, and in other areas of the
country; and
(4) A significant increase in allocation
of Federal resources is necessary to
respond adequately to drug-related
activities in the area.
The HIDTA Program helps improve
the effectiveness and efficiency of drug
control efforts by facilitating
cooperation among drug control
organizations through resource and
information sharing, collocation, and
implementing joint initiatives. HIDTA
funds help Federal, State, local, and
tribal law enforcement organizations
invest in infrastructure and joint
initiatives to confront drug trafficking
organizations.
E:\FR\FM\04JNN1.SGM
04JNN1
rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices
Each HIDTA is governed by its own
executive board comprised of Federal,
State and local law enforcement officials
from the designated HIDTA region. The
executive boards facilitate interagency
drug control efforts to eliminate or
reduce drug threats.
HIDTA-designated counties comprise
approximately 13 percent of U.S.
counties, and are present in 43 states,
Puerto Rice, the U.S. Virgin Islands, and
the District of Columbia. The following
28 areas are designated HIDTAs:
1990: Houston, Los Angeles, New York/
New Jersey, South Florida, and
Southwest Border (California,
Arizona, New Mexico, and South and
West Texas)
1994: Washington/Baltimore (Maryland,
Virginia, and District of Columbia)
and Puerto Rico/U.S. Virgin Islands
1995: Atlanta, Chicago, and
Philadelphia/Camden
1996: Rocky Mountain (Colorado,
Montana, Utah, and Wyoming), Gulf
Coast (Alabama, Louisiana, and
Mississippi), Lake County (Indiana),
Midwest (Iowa, Kansas, Missouri,
Nebraska, North Dakota, and South
Dakota) and Northwest (Washington)
1997: Michigan and Northern California
1998: Appalachia (Kentucky, Tennessee,
and West Virginia), Central Florida,
Milwaukee, and North Texas (Texas
and Oklahoma)
1999: Central valley California, Hawaii,
New England (Connecticut, New
Hampshire, Maine, Massachusetts,
Rhode Island, and Vermont), Ohio,
and Oregon
2001: North Florida and Nevada
To date, counties seeking HIDTA
designation have communicated their
interest to ONDCP in a variety of
manners. Currently, no formal process
or regulation exists outlining the
application and selection process.
Historically, law enforcement coalitions
interested in obtaining designation as
HIDTAs have submitted drug-related
threat assessments for their counties
which typically include a narrative
analysis of the drug threat and statistical
information related to the four statutory
criteria. The proposed rule is intended
to create a better coordinated and more
meaningful process for reviewing
applications. The rule sets forth a
general process that enables interested
coalitions of law enforcement agencies
to submit petition for designation as a
HIDTA. The criteria by which ONDCP
will evaluate the petitions are set forth
in this regulation. In addition, the
proposed rule requires ONDCP to
review submitted petitions of a regular
basis.
VerDate Aug<31>2005
20:34 Jun 01, 2007
Jkt 211001
Sec. 1
General Provisions
(a) This regulation contains the rules
that the Office of National Drug Control
Policy (Office) follows in processing
petitions for designation as a High
Intensity Drug Trafficking Area
(HIDTA), in accordance with the
ONDCP Reauthorization Act of 2006,
Public Law No. 109–469.
(b) Establishment—
(1) In General—There is established in
the Office a program known as the High
Intensity Drug Trafficking Areas
Program (in this regulation referred to as
the ‘‘Program’’).
(2) Purpose—The purpose of the
Program is to reduce drug trafficking
and drug production in the United
States by—
(A) Facilitating cooperation among
Federal, State, local, and tribal law
enforcement agencies to share
information and implement coordinated
enforcement activities;
(B) Enhancing law enforcement
intelligence sharing among Federal,
State, local, and tribal law enforcement
agencies;
(C) Providing reliable law
enforcement intelligence to law
enforcement agencies needed to design
effective enforcement strategies and
operations; and
(D) Supporting coordinated law
enforcement strategies which maximize
use of available resources to reduce the
supply of illegal drugs in designated
areas and in the United States as a
whole.
(c) Designation—
(1) In General—The Director, in
consultation with the Attorney General,
the Secretary of the Treasury, the
Secretary of Homeland Security, heads
of the National Drug Control Program
agencies, and the Governor of each
applicable State, may designate any
specified area of the United States as a
high intensity drug trafficking area.
(2) Activities—After making a
designation under paragraph (1) and in
order to provide Federal assistance to
the area so designated, the Director
may—
(A) Obligate such sums as are
appropriated for the Program;
(B) Direct the temporary reassignment
of Federal personnel to such area,
subject to the approval of the head of
the department or agency that employs
such personnel;
(C) Take any other action authorized
under the Office of National Drug
Control Policy Reauthorization Act of
2006 to provide increased Federal
assistance to those areas; and
(D) Coordinate activities under this
section (specifically administrative,
PO 00000
Frm 00121
Fmt 4703
Sfmt 4703
30863
recordkeeping, and funds management
activities) with State, local, and tribal
officials.
(3) Factors for Consideration—In
considering whether to designate an
area as a high intensity drug trafficking
area, the Director shall consider, in
addition to such other criteria as the
Director considers to be appropriate, the
extent to which—
(1) The area is a significant center of
illegal drug production, manufacturing,
importation, or distribution;
(2) State, local, and tribal law
enforcement agencies have committed
resources to respond to the drug
trafficking problem in the area, thereby
indicating a determination to respond
aggressively to the problem;
(3) Drug-related activities in the area
are having a significant harmful impact
in the area, and in other areas of the
country; and
(4) A significant increase in allocation
of Federal resources is necessary to
respond adequately to drug-related
activities in the area.
Sec. 2 Instructions for Petitions
(a) A coalition of interested law
enforcement agencies from an area may
petition for designation as a HIDTA.
(b) Petitions must specify the
geographical area for which HIDTA
designation is requested. Areas are
designated by county, therefore, such
areas must be identified in the petition.
(c) Petitions must state specifically
which law enforcement agencies are
making the petition, a responsible
official for each agency making the
petition, and a point of contact for the
coalition of interested law enforcement
agencies.
(d) Petitions must include an
assessment of the threat of illegal drugs
in the area for which HIDTA
designation is requested and must
specifically respond to each of the
following four requirements:
(1) The area is a significant center of
illegal drug production, manufacturing,
importation, or distribution;
(2) State, local, and tribal law
enforcement agencies have committed
resources to respond to the drug
trafficking problem in the area, thereby
indicating a determination to respond
aggressively to the problem;
(3) Drug-related activities in the area
are having a significant harmful impact
in the area, and in other areas of the
country; and
(4) A significant increase in allocation
of Federal resources is necessary to
respond adequately to drug-related
activities in the area.
(e) Each of the requirements in
Section 2(d) must be addressed and
E:\FR\FM\04JNN1.SGM
04JNN1
30864
Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices
justified with sufficient information/
documentation for each county
proposed in the petition.
(f) If the petition proposes to
designate additional counties to an
already established HIDTA region, the
petition shall include a letter from the
Chairman of that HIDTA’s Executive
Committee indicating that the Executive
Committee has reviewed the petition
and sets forth its position related to the
petition for designation.
(g) Petitions may be submitted to the
Executive Office of the President, Office
of National Drug Control Policy, Office
of State, Local and Tribal Affairs,
Washington, DC 20503 via facsimile at
(202) 395–6721 or electronic mail at
ondcp_hidta@ondcp.eop.gov.
Comments or questions regarding this
notice should be directed to Mr. Daniel
Grayson, ONDCP Policy Analyst at (202)
395–4582.
Sec. 3
Processing of Petitions
(a) Acknowledgements of Petitions.
Upon receipt of a petition, the Office
shall send an acknowledgement letter to
the requester to confirm receipt of the
petition and provide an assigned
number for further reference.
(b) Petitions will be reviewed by the
Office on a regular basis. The review
will include a recommendation
regarding the merit of the petition to the
Director by a panel of qualified,
independent experts who are designated
by the Director.
(c) Notification of merit of petition.
After the review is completed the
requestor will be notified in writing
regarding the disposition of the petition.
(d) The Director, Office of National
Drug Control Policy, is solely
responsible for making designation and
funding decisions relating to the HIDTA
Program.
Edward H. Jurith,
General Counsel, Office of National Drug
Control Policy.
[FR Doc. E7–10640 Filed 6–1–07; 8:45 am]
rwilkins on PROD1PC63 with NOTICES
BILLING CODE 3180–02–P
NUCLEAR REGULATORY
COMMISSION
[EA 07–019]
In the Matter of All Licensees
Authorized To Manufacture or Initially
Transfer Items Containing Radioactive
Material for Sale or Distribution and
Possess High-Risk Radioactive
Material of Concern; Order Imposing
Additional Security Measures
(Effective Immediately)
I
The Licensees identified in
Attachment 1 1 to this Order hold
licenses issued in accordance with the
Atomic Energy Act of 1954 by the U.S.
Nuclear Regulatory Commission (NRC
or Commission) or an Agreement State
authorizing them to manufacture or
initially transfer items containing
radioactive material for sale or
distribution. Commission regulations at
10 CFR 20.1801 or equivalent
Agreement State regulations require
Licensees to secure, from unauthorized
removal or access, licensed materials
that are stored in controlled or
unrestricted areas. Commission
regulations at 10 CFR 20.1802 or
equivalent Agreement States regulations
require Licensees to control and
maintain constant surveillance of
licensed material that is in a controlled
or unrestricted area and that is not in
storage.
II
On September 11, 2001, terrorists
simultaneously attacked targets in New
York, N.Y., and Washington, DC,
utilizing large commercial aircraft as
weapons. In response to the attacks and
intelligence information subsequently
obtained, the Commission issued a
number of Safeguards and Threat
Advisories to its Licensees in order to
strengthen Licensees’ capabilities and
readiness to respond to a potential
attack on a nuclear facility. The
Commission has also communicated
with other Federal, State and local
government agencies and industry
representatives to discuss and evaluate
the current threat environment in order
to assess the adequacy of security
measures at licensed facilities. In
addition, the Commission has been
conducting a review of its safeguards
and security programs and
requirements.
As a result of its consideration of
current safeguards and license
requirements, as well as a review of
information provided by the intelligence
1 Attachment 1 contains sensitive information
and will not be released to the public.
VerDate Aug<31>2005
20:34 Jun 01, 2007
Jkt 211001
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
community, the Commission has
determined that certain additional
security measures are required to be
implemented by Licensees as prudent
measures to address the current threat
environment. Therefore, the
Commission is imposing the
requirements set forth in Attachment 2 2
on certain Manufacturing and
Distribution licensees identified in
Attachment 1 of this Order who
currently possess, or have near term
plans to possess, high-risk radioactive
material of concern. These
requirements, which supplement
existing regulatory requirements, will
provide the Commission with
reasonable assurance that the public
health and safety and common defense
and security continue to be adequately
protected in the current threat
environment. Attachment 3 of this
Order contains the requirements for
fingerprinting and criminal history
record checks for individuals when
licensee’s reviewing official is
determining access to Safeguards
Information or unescorted access to the
radioactive materials. These
requirements will remain in effect until
the Commission determines otherwise.
The Commission recognizes that
Licensees may have already initiated
many measures set forth in Attachment
2 to this Order in response to previously
issued advisories or on their own. It is
also recognized that some measures may
not be possible or necessary at some
sites, or may need to be tailored to
accommodate the Licensees’ specific
circumstances to achieve the intended
objectives and avoid any unforeseen
effect on the safe use and storage of the
sealed sources. Although the additional
security measures implemented by the
Licensees in response to the Safeguards
and Threat Advisories have been
adequate to provide reasonable
assurance of adequate protection of
public health and safety, the
Commission concludes that the security
measures must be embodied in an Order
consistent with the established
regulatory framework. Furthermore, the
Commission has determined that some
of the security measures contained in
Attachment 2 of this Order contain
Safeguards Information and will not be
released to the public as per the NRC’s
‘‘Order Imposing Requirements for the
Protection of Certain Safeguards
Information’’ (EA–06–241 or EA–06–289
2 Attachment 2 contains some requirements that
are SAFEGUARDS INFORMATION, and cannot be
released to the public, and have therefore been
redacted. The remainder of the requirements
contained in Attachment 2 that are not
SAFEGUARDS INFORMATION will be released to
the public.
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 72, Number 106 (Monday, June 4, 2007)]
[Notices]
[Pages 30862-30864]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-10640]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
Office of National Drug Control Policy
High Intensity Drug Trafficking Areas; Petitions for Designation
AGENCY: Office of National Drug Control Policy.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Office of National Drug Control Policy
Reauthorization Act of 2006, Public Law 109-469, section 707(c), the
Director, National Drug Control Policy is establishing regulations
under which interested coalitions of law enforcement agencies from an
area may petition for designation as a high intensity drug trafficking
area.
DATES: Comments must be received by ONDCP on or before August 3, 2007.
ADDRESSES: Written comments may be submitted through electronic mail at
ondcp_hidta@ondcp.eop.gov, or via facsimile at (202) 395-6721 to
Executive Office of the President, Office of National Drug Control
Policy, Office of State, Local and Tribal Affairs, Washington, DC
20503.
FOR FURTHER INFORMATION CONTACT: Mr. Daniel Grayson, Policy Analyst,
Office of State, Local, and Tribal Affairs, Executive Office of the
President, Office of National Drug Control Policy, 750 17th Street,
NW., Washington, DC 20503; DGrayso@ondcp.eop.gov; (202) 395-4582 (This
is not a toll-free number).
SUPPLEMENTARY INFORMATION: The Anti-Drug Abuse Act of 1988, the ONDCP
Reauthorization Act of 1998, and the ONDCP Reauthorization Act of 2006
authorize the Director of the Office of National Drug Control Policy
(ONDCP) to designate areas within the United States that exhibit
serious drug trafficking problems and harmful impact of other areas of
the country as High Intensity Drug Trafficking Areas (HIDTA). The HIDTA
Program provides federal resources to those areas to help eliminate or
reduce drug trafficking and its harmful consequences. Law enforcement
organizations within HIDTAs assess drug trafficking problems and design
specific initiatives to reduce of eliminate the production,
manufacture, transportation, distribution, and use of illegal drugs and
money laundering.
When designating a new HIDTA or adding counties to existing HIDTAs,
the Director of ONDCP consults with the Attorney General, Secretary of
Homeland Security, Secretary of Treasury, heads of national drug
control agencies, and the appropriate governors, and considers the
extent to which--
(1) The area is a significant center of illegal drug production,
manufacturing, importation, or distribution;
(2) State, local, and tribal law enforcement agencies have
committed resources to respond to the drug trafficking problem in the
area, thereby indicating a determination to respond aggressively to the
problem;
(3) Drug-related activities in the area are having a significant
harmful impact in the area, and in other areas of the country; and
(4) A significant increase in allocation of Federal resources is
necessary to respond adequately to drug-related activities in the area.
The HIDTA Program helps improve the effectiveness and efficiency of
drug control efforts by facilitating cooperation among drug control
organizations through resource and information sharing, collocation,
and implementing joint initiatives. HIDTA funds help Federal, State,
local, and tribal law enforcement organizations invest in
infrastructure and joint initiatives to confront drug trafficking
organizations.
[[Page 30863]]
Each HIDTA is governed by its own executive board comprised of
Federal, State and local law enforcement officials from the designated
HIDTA region. The executive boards facilitate interagency drug control
efforts to eliminate or reduce drug threats.
HIDTA-designated counties comprise approximately 13 percent of U.S.
counties, and are present in 43 states, Puerto Rice, the U.S. Virgin
Islands, and the District of Columbia. The following 28 areas are
designated HIDTAs:
1990: Houston, Los Angeles, New York/New Jersey, South Florida, and
Southwest Border (California, Arizona, New Mexico, and South and West
Texas)
1994: Washington/Baltimore (Maryland, Virginia, and District of
Columbia) and Puerto Rico/U.S. Virgin Islands
1995: Atlanta, Chicago, and Philadelphia/Camden
1996: Rocky Mountain (Colorado, Montana, Utah, and Wyoming), Gulf Coast
(Alabama, Louisiana, and Mississippi), Lake County (Indiana), Midwest
(Iowa, Kansas, Missouri, Nebraska, North Dakota, and South Dakota) and
Northwest (Washington)
1997: Michigan and Northern California
1998: Appalachia (Kentucky, Tennessee, and West Virginia), Central
Florida, Milwaukee, and North Texas (Texas and Oklahoma)
1999: Central valley California, Hawaii, New England (Connecticut, New
Hampshire, Maine, Massachusetts, Rhode Island, and Vermont), Ohio, and
Oregon
2001: North Florida and Nevada
To date, counties seeking HIDTA designation have communicated their
interest to ONDCP in a variety of manners. Currently, no formal process
or regulation exists outlining the application and selection process.
Historically, law enforcement coalitions interested in obtaining
designation as HIDTAs have submitted drug-related threat assessments
for their counties which typically include a narrative analysis of the
drug threat and statistical information related to the four statutory
criteria. The proposed rule is intended to create a better coordinated
and more meaningful process for reviewing applications. The rule sets
forth a general process that enables interested coalitions of law
enforcement agencies to submit petition for designation as a HIDTA. The
criteria by which ONDCP will evaluate the petitions are set forth in
this regulation. In addition, the proposed rule requires ONDCP to
review submitted petitions of a regular basis.
Sec. 1 General Provisions
(a) This regulation contains the rules that the Office of National
Drug Control Policy (Office) follows in processing petitions for
designation as a High Intensity Drug Trafficking Area (HIDTA), in
accordance with the ONDCP Reauthorization Act of 2006, Public Law No.
109-469.
(b) Establishment--
(1) In General--There is established in the Office a program known
as the High Intensity Drug Trafficking Areas Program (in this
regulation referred to as the ``Program'').
(2) Purpose--The purpose of the Program is to reduce drug
trafficking and drug production in the United States by--
(A) Facilitating cooperation among Federal, State, local, and
tribal law enforcement agencies to share information and implement
coordinated enforcement activities;
(B) Enhancing law enforcement intelligence sharing among Federal,
State, local, and tribal law enforcement agencies;
(C) Providing reliable law enforcement intelligence to law
enforcement agencies needed to design effective enforcement strategies
and operations; and
(D) Supporting coordinated law enforcement strategies which
maximize use of available resources to reduce the supply of illegal
drugs in designated areas and in the United States as a whole.
(c) Designation--
(1) In General--The Director, in consultation with the Attorney
General, the Secretary of the Treasury, the Secretary of Homeland
Security, heads of the National Drug Control Program agencies, and the
Governor of each applicable State, may designate any specified area of
the United States as a high intensity drug trafficking area.
(2) Activities--After making a designation under paragraph (1) and
in order to provide Federal assistance to the area so designated, the
Director may--
(A) Obligate such sums as are appropriated for the Program;
(B) Direct the temporary reassignment of Federal personnel to such
area, subject to the approval of the head of the department or agency
that employs such personnel;
(C) Take any other action authorized under the Office of National
Drug Control Policy Reauthorization Act of 2006 to provide increased
Federal assistance to those areas; and
(D) Coordinate activities under this section (specifically
administrative, recordkeeping, and funds management activities) with
State, local, and tribal officials.
(3) Factors for Consideration--In considering whether to designate
an area as a high intensity drug trafficking area, the Director shall
consider, in addition to such other criteria as the Director considers
to be appropriate, the extent to which--
(1) The area is a significant center of illegal drug production,
manufacturing, importation, or distribution;
(2) State, local, and tribal law enforcement agencies have
committed resources to respond to the drug trafficking problem in the
area, thereby indicating a determination to respond aggressively to the
problem;
(3) Drug-related activities in the area are having a significant
harmful impact in the area, and in other areas of the country; and
(4) A significant increase in allocation of Federal resources is
necessary to respond adequately to drug-related activities in the area.
Sec. 2 Instructions for Petitions
(a) A coalition of interested law enforcement agencies from an area
may petition for designation as a HIDTA.
(b) Petitions must specify the geographical area for which HIDTA
designation is requested. Areas are designated by county, therefore,
such areas must be identified in the petition.
(c) Petitions must state specifically which law enforcement
agencies are making the petition, a responsible official for each
agency making the petition, and a point of contact for the coalition of
interested law enforcement agencies.
(d) Petitions must include an assessment of the threat of illegal
drugs in the area for which HIDTA designation is requested and must
specifically respond to each of the following four requirements:
(1) The area is a significant center of illegal drug production,
manufacturing, importation, or distribution;
(2) State, local, and tribal law enforcement agencies have
committed resources to respond to the drug trafficking problem in the
area, thereby indicating a determination to respond aggressively to the
problem;
(3) Drug-related activities in the area are having a significant
harmful impact in the area, and in other areas of the country; and
(4) A significant increase in allocation of Federal resources is
necessary to respond adequately to drug-related activities in the area.
(e) Each of the requirements in Section 2(d) must be addressed and
[[Page 30864]]
justified with sufficient information/documentation for each county
proposed in the petition.
(f) If the petition proposes to designate additional counties to an
already established HIDTA region, the petition shall include a letter
from the Chairman of that HIDTA's Executive Committee indicating that
the Executive Committee has reviewed the petition and sets forth its
position related to the petition for designation.
(g) Petitions may be submitted to the Executive Office of the
President, Office of National Drug Control Policy, Office of State,
Local and Tribal Affairs, Washington, DC 20503 via facsimile at (202)
395-6721 or electronic mail at ondcp_hidta@ondcp.eop.gov.
Comments or questions regarding this notice should be directed to
Mr. Daniel Grayson, ONDCP Policy Analyst at (202) 395-4582.
Sec. 3 Processing of Petitions
(a) Acknowledgements of Petitions. Upon receipt of a petition, the
Office shall send an acknowledgement letter to the requester to confirm
receipt of the petition and provide an assigned number for further
reference.
(b) Petitions will be reviewed by the Office on a regular basis.
The review will include a recommendation regarding the merit of the
petition to the Director by a panel of qualified, independent experts
who are designated by the Director.
(c) Notification of merit of petition. After the review is
completed the requestor will be notified in writing regarding the
disposition of the petition.
(d) The Director, Office of National Drug Control Policy, is solely
responsible for making designation and funding decisions relating to
the HIDTA Program.
Edward H. Jurith,
General Counsel, Office of National Drug Control Policy.
[FR Doc. E7-10640 Filed 6-1-07; 8:45 am]
BILLING CODE 3180-02-P
